Back to Search
DAVID SCHEINBERG, MD
MD
Medical Oncology Physician
NPI: 1871564633Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
156274(NY)
Research & Publications (20)
Structure and activity of human mitochondrial peptide deformylase, a novel cancer target.
PMID 19236878·J Mol Biol·2009
8-other
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.
PMID 19075280·J Clin Oncol·2009
4-observational
Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial.
PMID 19536894·Cancer·2009
3-trial
Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes.
PMID 19367842·Nano Lett·2008
8-other
Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications.
PMID 18514364·Adv Drug Deliv Rev·2008
6-review
Non-natural and photo-reactive amino acids as biochemical probes of immune function.
PMID 19079589·PLoS One·2008
8-other
Toward a prostate specific antigen-based prostate cancer diagnostic assay: preparation of keyhole limpet hemocyanin-conjugated normal and transformed prostate specific antigen fragments.
PMID 18798614·J Am Chem Soc·2008
8-other
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease.
PMID 18256684·Leukemia·2008
8-other
Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.
PMID 18829561·Cancer Res·2008
7-preclinical
PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice.
PMID 17878942·PLoS One·2007
7-preclinical
High-throughput identification of inhibitors of human mitochondrial peptide deformylase.
PMID 17435169·J Biomol Screen·2007
4-observational
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.
PMID 17575055·Genes Dev·2007
7-preclinical
Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes.
PMID 17607040·J Nucl Med·2007
7-preclinical
Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
PMID 17671141·Clin Cancer Res·2007
8-other
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor.
PMID 17717602·J Clin Invest·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1871564633
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile